AMIRA MEDICAL ATLAST BLOOD GLUCOSE MONITORING SYSTEM— 510(k) K982076

Name: FDA 510(k) clearance K982076
Creator: U.S. Food and Drug Administration
Published: 1998-12-10

Substantially Equivalent

Amira Medical, Inc.

FDA 510(k) clearance K982076 for AMIRA MEDICAL ATLAST BLOOD GLUCOSE MONITORING SYSTEM, Substantially Equivalent on 1998-12-10. Applicant: Amira Medical, Inc.. Device class: 2.

Clearance details

Applicant: Amira Medical, Inc.
Product code: Code CGA
Device class: Class 2
Regulation: 21 CFR 862.1345
Advisory panel: Clinical Chemistry
Date received: 1998-06-12
Decision date: 1998-12-10
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Scotts Valley, CA, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code CGA

view all

K252488 — ABL90 FLEX PLUS System2026-05-01
K210933 — YSI 2900C Biochemistry Analyzer2024-09-30
K220328 — EasyStat 3002024-07-26
K223179 — Cholestech LDX System2023-09-20
K223755 — i-STAT G cartridge with the i-STAT 1 System2023-09-11

More clearances from Amira Medical, Inc.

view all

K010605 — ATLAST DATA MANAGEMENT SOFTWARE (DMS)2001-05-07
K991075 — ATLAST GLUCOSE CONTROL SOLUTION1999-05-10

Adverse events under product code CGA

product code CGA

Death: 2
Malfunction: 1,816
Total: 1,818

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.